Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Möhler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
A longitudinal single-center cohort study on the prevalence and risk of accessory saphenous vein reflux after radiofrequency segmental thermal ablation of great saphenous veinsThomas M Proebstle, Thomas Möhler
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2016
ReplyThomas M Proebstle, Thomas Möhler
Anti-Cancer Drugs|September 10, 2003
Inhibition of angiogenesis by non-toxic doses of temozolomideHjalmar Kurzen, Stefan Schmitt, Helmut Näher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 21, 2010
[Erythematosus plaques and nodules in a 50-year old patient with rheumatoid arthritis. Interstitial granulomatous dermatitis with arthritis]Stephan Rietz, Thomas Möhler, Wolfgang Bräuninger, et al.
Cancer Research|July 4, 2003
Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapyMartina Willhauck, Carmen Scheibenbogen, Michael Pawlita, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|October 11, 2017
A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein refluxThomas M Proebstle, Bettina Kleis-Fischer, Thomas Möhler, et al.
Cancer Gene Therapy|June 26, 2002
Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotidesRalf Kronenwett, Thorsten Gräf, Wolfgang Nedbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2011
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routineTobias Meissner, Anja Seckinger, Thierry Rème, et al.
Blood|September 2, 2006
CD200 is a new prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Thierry Reme, et al.
Blood|March 21, 2009
Induction of angiogenesis by normal and malignant plasma cellsDirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
A longitudinal single-center cohort study on the prevalence and risk of accessory saphenous vein reflux after radiofrequency segmental thermal ablation of great saphenous veinsThomas M Proebstle, Thomas Möhler
Journal of Vascular Surgery. Venous and Lymphatic Disorders|June 19, 2016
ReplyThomas M Proebstle, Thomas Möhler
Anti-Cancer Drugs|September 10, 2003
Inhibition of angiogenesis by non-toxic doses of temozolomideHjalmar Kurzen, Stefan Schmitt, Helmut Näher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 21, 2010
[Erythematosus plaques and nodules in a 50-year old patient with rheumatoid arthritis. Interstitial granulomatous dermatitis with arthritis]Stephan Rietz, Thomas Möhler, Wolfgang Bräuninger, et al.
Cancer Research|July 4, 2003
Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapyMartina Willhauck, Carmen Scheibenbogen, Michael Pawlita, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|October 11, 2017
A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein refluxThomas M Proebstle, Bettina Kleis-Fischer, Thomas Möhler, et al.
Cancer Gene Therapy|June 26, 2002
Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotidesRalf Kronenwett, Thorsten Gräf, Wolfgang Nedbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2011
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routineTobias Meissner, Anja Seckinger, Thierry Rème, et al.
Blood|September 2, 2006
CD200 is a new prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Thierry Reme, et al.
Blood|March 21, 2009
Induction of angiogenesis by normal and malignant plasma cellsDirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
Pageof 2